Acknowledgements
The ChEMBL resources are made available due to funding from the following:
Current Awards
Ongoing: The Member States of the European Molecular Biology Laboratory (EMBL)
2020-2024: Wellcome Trust (Strategic Award 218244/Z/19/Z)
2024-2025: Wellcome Trust (Preparatory and ChEMBL/EVA Bridge 228142/Z/23/Z)
2014-2026: Open Targets
2020-2025: European Commission/IMI2 EUbOPEN: Enabling and unlocking biology in the OPEN (875510)
Past Awards
2018-2023: Illuminating the Druggable Genome NIH grant 1U24CA224370-01
2014-2019: Wellcome Trust (Strategic Award WT086151/Z/08/Z).
2016-2022: European Commission Horizon 2020. Toxicity Testing and Risk Assessment in the 21st Century EU-ToxRisk (681002)
2015-2019: Coordinated Research Infrastructures Building Enduring Life-science Services CORBEL (654248)
2017-2022: European Commission/IMI2 eTRANSAFE - Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management (777365)
2017-2021: European Commission/IMI2/TransQST - Translational quantitative systems toxicology to improve the understanding of the safety of medicines (116030)
2013-2018: European Commission FP7 HeCaTos - Safety prediction (602156)
2009-2016: European Commission/IMI IMI eTox (115002)
2014-2016: Illuminating the Druggable Genome NIH grant 1U54CA189205-01
2008-2014: Chemogenomics at the EBI, WT Strategic award 086151/Z/08/Z
2012-2015: European Commission FP7 BioMedBridges (284209)
2014-2014: Pistoia Alliance Application of HELM Nomenclature to ChEMBL peptide content.
2012-2014: Medicines for Malaria Ventures - Malaria Data Deposition Portal
2012-2014: European Commission/IMI IMI Open PHACTS (115191)
2011-2014: European Commission FP7 DiXa (283775)
2011-2014: BBSRC/EPSRC/MRC SMSDrug.net - Chemical Biology Networking (EP/I037229/1)
2013-2013: Syngenta - Herbicide and Insecticide Data for ChEMBL
2011-2013: GSK - ADMET SARfari
2009-2013: European Commission ESFRI EU-OpenScreen (261861)
2010-2011: Pfizer - Druggability Analysis
Last updated